Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

Published:2021-09-27 Issue:40 Volume:42 Page:4123-4125
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ruilope Luis M¹²³^ORCID,Valenzuela Pedro L³^ORCID,Lucia Alejandro³⁴^ORCID

Affiliation:

1. Cardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain

2. CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain

3. Faculty of Sport Sciences, European University of Madrid, Spain

4. Research Institute of the Hospital Universitario 12 de Octubre (imas12, PaHerg group), Madrid, Spain

Funder

Spanish Ministry of Economy and Competitiveness and Fondos Feder

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/42/40/4123/40810348/ehab694.pdf

Reference14 articles.

1. 2018 ESC/ESH Guidelines for the management of arterial hypertension;Williams;Eur Heart J,2018

2. Heart disease and stroke statistics—2020 update: A report from the American Heart Association;Virani;Circulation,2020

3. Lifestyle interventions for the prevention and treatment of hypertension;Valenzuela;Nat Rev Cardiol,2021

4. Benefits and harms of antihypertensive treatment in low-risk patients with mild hypertension;Sheppard;JAMA Intern Med,2018

5. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure;Naci;Br J Sports Med,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The acceptability and effectiveness of artificial intelligence-based chatbot for hypertensive patients in community: protocol for a mixed-methods study;BMC Public Health;2024-08-21

2. The acceptability and effectiveness of artificial intelligence-based chatbot for hypertensive patients in community: protocol for a mixed-methods study;2024-02-02

3. Digital Therapeutics: Emerging New Therapy for Nonalcoholic Fatty Liver Disease;Clinical and Translational Gastroenterology;2023-03-01

4. Update on a silent killer: arterial hypertension;European Heart Journal;2022-10-07

5. Stop smoking and sleep well to reduce cardiovascular risk;European Heart Journal;2021-10-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3